As for its effect in acute allergic reactions (especially anaphylaxis), one would expect the IgE blockade to have an immediate effect on allergic asthma as well, but this is not the case; omalizumab does not play a central role in the management of allergic exacerbations of acute clinical asthma. This evidence concerns the gene IGHE and allergic asthma.